A Case of T/NK-Cell Post-Transplantation Lymphoproliferative Disease 7 Years after Heart Transplantation
Post-transplant lymphoproliferative diseases (PTLD) are potentially fatal complications after cardiac transplantation. Most cases are Epstein–Barr virus (EBV)-related B-cell tumors, and reduction of immunosuppression treatment as well as the use of rituximab in combination with other chemotherapy ar...
Main Authors: | Makiko Nakamura, Teruhiko Imamura, Kohji Takagi, Masakazu Hori, Shinichi Tanaka, Joji Imura, Koichiro Kinugawa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Journal of Cardiovascular Development and Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2308-3425/9/2/38 |
Similar Items
-
First Report of an SH2D1A Mutation Associated with X-Linked Lymphoproliferative Disease in Turkey
by: Selman Kesici, et al.
Published: (2018-08-01) -
Lymphoproliferative disorder after kidney transplantation
by: Petrović Lada, et al.
Published: (2018-01-01) -
Viral markers in patients with hemophagocytosis: A prospective study in a tertiary care hospital
by: Baijayantimala Mishra, et al.
Published: (2012-01-01) -
Post-transplant lymphoproliferative disease
by: Nieto-Ríos, John Fredy, et al.
Published: (2016-07-01) -
Immunosupression in liver transplant for hepatocellular carcinoma
by: Juan Carlos Restrepo Restrepo
Published: (2007-02-01)